Adimmune (TPE:4142) Inventories, Other: NT$907 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4142 Adimmune Corp TPE:4142
58 GF Score
Price NT$17.20
GF Value NT$22.52
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Adimmune Inventories, Other?

Adimmune TPE:4142 -1.71% 58 Inventories, Other is NT$907 Mil as of Jun. 2026. GuruFocus rates TPE:4142 with a GF Score™ of 58/100 and a GF Value™ of NT$22.52 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Adimmune's other inventories for the quarter that ended in Jun. 2026 was NT$907 Mil.

Adimmune's quarterly other inventories increased from Dec. 2025 (NT$571 Mil) to Mar. 2026 (NT$593 Mil) and increased from Mar. 2026 (NT$593 Mil) to Jun. 2026 (NT$907 Mil).

Adimmune's annual other inventories increased from Dec. 2023 (NT$526 Mil) to Dec. 2024 (NT$628 Mil) but then declined from Dec. 2024 (NT$628 Mil) to Dec. 2025 (NT$571 Mil).

Adimmune Inventories, Other Historical Data

* Premium members only.

The historical data trend for Adimmune's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adimmune Inventories, Other Chart

Adimmune Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 505.88 659.33 526.41 627.99 571.08

Adimmune Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 926.73 786.05 571.08 592.85 907.27
TPE:4142
58GF Score
Adimmune Corp TPE:4142
Inventories, Other is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adimmune Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Frequently Asked Questions Learn more about Inventories, Other →
What does a Inventories, Other of NT$907 Mil mean?
Adimmune (TPE:4142) has a Inventories, Other of NT$907 Mil as of Jun. 2026. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Adimmune and its competitors.
Is Adimmune's Inventories, Other too high?
Adimmune's current Inventories, Other is NT$907 Mil. Overall, Adimmune has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Adimmune's Inventories, Other compare to VRTX and REGN?
Adimmune's Inventories, Other of NT$907 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Other for a Biotechnology company?
A good Inventories, Other depends on the Biotechnology industry context. However, Inventories, Other should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Other mean?
A high Inventories, Other can signal that a stock is expensive relative to its fundamentals. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Adimmune and its competitors. Adimmune's current Inventories, Other is NT$907 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adimmune stock overvalued right now?
Based on GuruFocus' analysis, Adimmune (TPE:4142) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$22.52, compared to a current price of NT$17.20 — trading 23.6% below its estimated fair value. The current Inventories, Other is NT$907 Mil. Adimmune's overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Other calculated?
Inventories, Other is calculated from a company's financial statements. For Adimmune (TPE:4142), the current Inventories, Other is NT$907 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adimmune (TPE:4142) Overvalued in 2026?

Based on GuruFocus' analysis, Adimmune stock appears to be undervalued. The current stock price of NT$17.20 is trading 23.6% below its estimated GF Value™ of NT$22.52. GuruFocus considers Adimmune to be Modestly Undervalued.

Key valuation signals for TPE:4142:

  • Inventories, Other: NT$907 Mil
  • GF Value™: NT$22.52 vs. price of NT$17.20 (23.6% below fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the TPE:4142 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adimmune Business Description

Address Tanxing Road, No. 3, Section 1, Tanzi District, Taichung City, TWN, 427003
Adimmune Corp is engaged in the research and development, processing, manufacturing, and trading of serum, vaccines, testing reagents, biologicals, and other bacterial fluids, as well as western medicines, animal medicines, chemicals, and feed additives. Its segments are separated by business as Adimmune Corporation, which generates maximum revenue and is engaged in the manufacturing of influenza vaccines with EU GMP and US FDA certificates in Taiwan. Its products include Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, and others, and Enimmune Corporation. The Group's revenue is mainly from the manufacturing and trading of vaccines, modern medicine products and testing reagents, as well as entrusted packing of vaccines.
58GF Score

Get the complete analysis for TPE:4142

Inventories, Other is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.20
Price
NT$22.52
GF Value